Morris, Nichols, Arsht & Tunnell and Irell & Manella filed a patent infringement lawsuit on April 5 in Delaware District Court on behalf of Actelion Pharmaceuticals Ltd. The complaint, which ...

The High Court has rebuffed Vanda’s bid to contest the May 2023 ruling from the U.S. Court of Appeals for the Federal Circuit ...

Aurlumyn, manufactured by Actelion Pharmaceuticals US, Inc., is an injection to treat severe frostbite in adults to reduce ...

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, ...

As far as J&J is concerned, the PAH franchise was added to its portfolio with the 2017 acquisition of Actelion. J&J’s key PAH ...

ZURICH: US healthcare giant Johnson & Johnson will buy Swiss biotech company Actelion in a US$30bil all-cash deal that includes spinning off Actelion’s research and development pipeline ...

But Portela had a problem: She needed a doctor to sign on as the principal investigator (PI) for the trial sponsored by Actelion Pharmaceuticals and run by the clinical research organization (CRO ...

Johnson & Johnson acquired Actelion for $30 billion in cash in 2017. The company combined it with Janssen Pharmaceuticals to expand Janssen's portfolio and late-stage pipeline. Actelion developed ...

Pisano, Gary P., Daniela Beyersdorfer, and Ruth Dittrich. "Innovation and Growth at Actelion Ltd." Harvard Business School Case 611-065, March 2011. (Revised February 2012.) ...

Here are the best and worst pharma deals of the decade, from Merck's acquisition of a blockbuster cancer drug to J&J's $30 billion busted Actelion takeover A self-driving-car pioneer teamed up ...

On Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed ...